TrialDrugs in R&D2013

Efficacy and safety of a fixed combination of irbesartan/hydrochlorothiazide in Chinese patients with moderate to severe hypertension.

Qi-Fang Huang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.